IP Library › Granted Patent US 10,639,505
Granted Patent B2
US 10,639,505 · App. 15/854,504 · Granted May 5, 2020

Methods for fixing hair and skin

Inventors: Eric D. Pressly (Santa Barbara, CA); Craig J. Hawker (Santa Barbara, CA)
Assignee: Olaplex, Inc.
A61Q5/12A61K8/0204A61K8/0216A61K8/22A61K8/36A61K8/362A61K8/365A61K8/40A61K8/41A61K8/447A61K8/45A61K8/46A61Q5/002A61Q5/004A61Q5/02A61Q5/04A61Q5/08A61Q5/10A61Q19/007A61K2800/42A61K2800/596A61K2800/70A61K2800/884A61K2800/94
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,639,505
App. No.
15/854,504
Granted
May 5, 2020
Kind
B2
Abstract

Compositions, kits, and methods for repairing bonds, for example, disulfide bonds, in hair or on the skin are disclosed. The compositions provide improved conditioning benefit for dry hair or moisturize the skin. The compositions also provide a long lasting moisturized feel and smooth feel to the skin or hair, without feeling greasy. The compositions contain one or more compounds that covalently bind at least two thiol groups in the hair or on the skin. Use of the binding compositions prevents reversion of the repaired bonds to their free thiol state, for at least one week or one month, or more, after a single application of the composition. Improved methods of styling hair, for example permanent hair waving, hair curling, hair coloring or highlighting, and hair straightening, are also provided.

Claims (19)

1. A keratin treatment formulation comprising an effective amount of a binding agent, wherein the binding agent is:

2. The keratin treatment formulation of claim 1 , further comprising one or more cosmetically acceptable excipients, wherein the one or more cosmetically acceptable excipients are selected from the group consisting of water, surfactants, vitamins, natural extracts, preservatives, antioxidants, chelating agents, proteins, amino acids, humectants, fragrances, emollients, penetrants, thickeners, viscosity modifiers, hair fixatives, film formers, emulsifiers, opacifying agents, propellants, liquid vehicles, carriers, salts, pH adjusting agents, neutralizing agents, buffers, hair conditioning agents, anti-static agents, anti-frizz agents, anti-dandruff agents, and combinations thereof.

3. The keratin treatment formulation of claim 2 , wherein the one or more cosmetically acceptable excipients are present in an amount ranging from 10 wt % to 90 wt % of the keratin treatment formulation.

4. The keratin treatment formulation of claim 1 , wherein the binding agent is present in an amount ranging from 0.01 wt % to 50 wt % of the keratin treatment formulation.

5. The keratin treatment formulation of claim 1 , wherein the binding agent is present in an amount ranging from 2.5 wt % to 3 wt % of the keratin treatment formulation.

6. The keratin treatment formulation of claim 1 , wherein the keratin treatment formulation is in the form of a shampoo.

7. The keratin treatment formulation of claim 6 , wherein the binding agent is:

8. The keratin treatment formulation of claim 1 , wherein the keratin treatment formulation is in the form of a conditioner.

9. The keratin treatment formulation of claim 8 , wherein the binding agent is:

10. The keratin treatment formulation of claim 1 , wherein the keratin treatment formulation is in the form of a milk.

11. The keratin treatment formulation of claim 1 , wherein the keratin treatment formulation is in the form of a gel.

12. The keratin treatment formulation of claim 1 , wherein the keratin treatment formulation is in the form of a liquid.

13. The keratin treatment formulation of claim 1 , wherein the keratin treatment formulation is in the form of a cream.

14. The keratin treatment formulation of claim 1 , wherein the keratin treatment formulation is in the form of a lotion.

15. The keratin treatment formulation of claim 1 , wherein the binding agent is present in an amount ranging from 1 wt % to 15 wt % of the keratin treatment formulation.

16. The keratin treatment formulation of claim 1 , wherein the binding agent is present in an amount ranging from 1 wt % to 10 wt % of the keratin treatment formulation.

17. The keratin treatment formulation of claim 1 , further comprising one or more cosmetically acceptable excipients, wherein the one or more cosmetically acceptable excipients are selected from the group consisting of surfactants, vitamins, natural extracts, preservatives, antioxidants, humectants, fragrances, emollients, thickeners, viscosity modifiers, emulsifiers, pH adjusting agents, hair conditioning agents, anti-static agents, and combinations thereof.

18. A keratin treatment formulation comprising water, preservatives, and an effective amount of a binding agent, wherein the binding agent is:

19. A keratin treatment formulation comprising water, glycerin, propylene glycol, cetearyl alcohol, phenoxyethanol, behentrimonium methosulfate, quaternium-91, stearamidopropyl dimethylamine, and an effective amount of a binding agent, wherein the binding agent is:

Assignments (6)
RELEASE OF SECURITY INTEREST AT R/F 059072/0192 Recorded Jul 8, 2026
From: GOLDMAN SACHS BANK USA
To: OLAPLEX, INC.
Reel/Frame 075927/0989 →
SECURITY INTEREST Recorded Feb 23, 2022
From: OLAPLEX, INC.
To: GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 059072/0192 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (PATENTS) Recorded Feb 23, 2022
From: MIDCAP FINANCIAL TRUST, AS ADMINISTRATIVE AGENT
To: OLAPLEX, INC.
Reel/Frame 059220/0993 →
SECURITY INTEREST Recorded Jan 9, 2020
From: OLAPLEX, INC.
To: MIDCAP FINANCIAL TRUST, AS THE ADMINISTRATIVE AGENT
Reel/Frame 051465/0319 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2020
From: LIQWD, INC.
To: OLAPLEX, INC.
Reel/Frame 051448/0450 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 26, 2017
From: PRESSLY, ERIC D.; HAWKER, CRAIG J.
To: LIQWD, INC.
Reel/Frame 044974/0737 →
Continuity (16)
Continuation 14835223 · Aug 25, 2015
Continuation 14748831 · Jun 24, 2015
Continuation 14459012 · Aug 13, 2014
Continuation In Part PCTUS2014049388 · Aug 1, 2014
Continuation In Part 14257056 · Apr 21, 2014
Continuation In Part 14257089 · Apr 21, 2014
Continuation In Part 14257076 · Apr 21, 2014
Provisional Application 62000340 · May 19, 2014
Provisional Application 61861281 · Aug 1, 2013
Provisional Application 61885898 · Oct 2, 2013
Provisional Application 61861281 · Aug 1, 2013
Provisional Application 61867872 · Aug 20, 2013
Provisional Application 61903239 · Nov 12, 2013
Provisional Application 61861281 · Aug 1, 2013
Provisional Application 61885898 · Oct 2, 2013
Related Publication 20180117367A1 · May 3, 2018
Cited By (3)
US 12,214,225 US 12,233,289 US 12,251,456